ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2017

PPAR-α Agonist Fenofibrate Reduces Insulin Resistance in Impaired Glucose Tolerance Patients with Hypertriglyceridemia: A Cross-Sectional Study.

Xiaomeng Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.